We are live on ! Find out more

16 hedge funds and large institutions have $515K invested in Imunon in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0% more capital invested

Capital invested by funds: $513K → $515K (+$1.86K)

0.09% less ownership

Funds ownership: 0.43%0.34% (-0.09%)

11% less funds holding

Funds holding: 1816 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
5
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change

IMNN Hedge Fund Activity: Q2 2023 in Review

16 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2023, worth a combined $515K — up 0.36% from $513K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of IMNN and 0 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $15.7K. The largest seller was Virtu Financial, exiting entirely with an estimated $17K sold.

  • 16 institutional investors held Imunon (IMNN) as of Q2 2023, down from 18 in Q1 2023.
  • Funds reported $515K of Imunon stock for Q2 2023, up 0.36% quarter-over-quarter.
  • 0 funds opened new Imunon positions in Q2 2023 and 2 closed out, a net change of -2 holders.
  • The largest Imunon buyer in Q2 2023 was Renaissance Technologies, an estimated $15.7K added.
  • The largest Imunon seller in Q2 2023 was Virtu Financial, an estimated $17K sold.

Based on aggregated 13F filings for Q2 2023.